Bioquest Corp Financials
This page shows Bioquest Corp (BQST) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
We are recalculating Bioquest Corp's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.
Key Financial Metrics
Earnings & Revenue
Cash & Balance Sheet
Bioquest Corp held $15K in cash against $0 in long-term debt as of fiscal year 2022.
Bioquest Corp had 11.49B shares outstanding in fiscal year 2022.
Margins & Returns
Capital Allocation
BQST Income Statement
| Metric | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $2K | N/A | N/A | N/A | $16K | N/A | $44K+186.1% | $15K |
| Operating Income | -$50K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | $24K | N/A | N/A | $13K-71.3% | $45K | N/A | $17K+1424.1% | $1K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS (Diluted) | N/A | N/A | $0.00 | N/A | N/A | N/A | $-0.08 | N/A |
BQST Balance Sheet
| Metric | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15K-55.4% | $34K+28813.8% | $116-98.3% | $7K-51.6% | $14K-17.1% | $17K-23.3% | $22K+37.0% | $16K |
| Current Assets | $15K-55.4% | $34K+28813.8% | $116-98.3% | $7K-51.6% | $14K-17.1% | $17K-23.3% | $22K+37.0% | $16K |
| Cash & Equivalents | $15K-55.4% | $34K+28813.8% | $116-85.8% | $818-70.1% | $3K+952.3% | $260+333.3% | $60-14.3% | $70 |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $551K+18.2% | $467K+18.5% | $394K-12.6% | $451K-79.1% | $2.2M+20.7% | $1.8M+21.7% | $1.5M+79.1% | $819K |
| Current Liabilities | $551K+18.2% | $467K+18.5% | $394K-12.6% | $451K-79.1% | $2.2M+20.7% | $1.8M+25.1% | $1.4M+83.2% | $779K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$536K-23.9% | -$433K-10.0% | -$394K+11.3% | -$444K+79.3% | -$2.1M-21.0% | -$1.8M-22.4% | -$1.4M-80.0% | -$803K |
| Retained Earnings | -$10.8M-1.2% | -$10.7M-2.4% | -$10.4M+0.5% | -$10.5M-1.8% | -$10.3M-4.4% | -$9.8M-2401.3% | -$394K-104.6% | $8.5M |
BQST Cash Flow Statement
| Metric | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$19K+64.0% | -$52K | N/A | -$2K+96.9% | -$63K-1126.0% | -$5K+88.1% | -$43K+9.6% | -$48K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | N/A | $85K | $0 | $0-100.0% | $65K+1126.4% | $5K-87.7% | $43K-4.4% | $45K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
BQST Financial Ratios
| Metric | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | 0.03-0.0 | 0.07+0.1 | 0.00-0.0 | 0.020.0 | 0.010.0 | 0.010.0 | 0.020.0 | 0.02 |
| Debt-to-Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$536K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.03), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What are Bioquest Corp's total assets?
Bioquest Corp (BQST) had $15K in total assets as of fiscal year 2022, including both current and long-term assets.
What is Bioquest Corp's current ratio?
Bioquest Corp (BQST) had a current ratio of 0.03 as of fiscal year 2022, which is below 1.0, which may suggest potential liquidity concerns.
Why is Bioquest Corp's debt-to-equity ratio negative or not reported?
Bioquest Corp (BQST) has negative shareholder equity of -$536K as of fiscal year 2022, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.